Oyster Point Pharma OverviewOyster Point Pharma Research & Development
Research & Development expenses for OYST.
Quarterly R&D Expenses
$3.91M
↓ 37.03% YoY
As of Sep 30, 2022
Annual R&D Expenses (TTM)
$18.72M
↓ 38.58% YoY
Trailing 12 months ending Sep 30, 2022